(Q64066490)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

title

Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet's uveitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

0 references

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Jing Shi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Chan Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Jiaxin Zhou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Jinjing Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Li Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Fei Gao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Xiaofeng Zeng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Meifen Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

language of work or name

English

0 references

publication date

6 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic advances in chronic disease

27 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

2040622319847881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders

27 April 2020

cites work

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

12 December 2020

Beneficial effects of interferon-alpha 2b in Behçet's disease

1 reference

12 December 2020

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study

1 reference

12 December 2020

Reactivation tuberculosis in a patient with anti-TNF-alpha treatment

1 reference

12 December 2020

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

12 December 2020

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

1 reference

12 December 2020

Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study

1 reference

12 December 2020

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

1 reference

12 December 2020

Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease

1 reference

12 December 2020

The use of interferon alpha in Behçet disease: review of the literature

1 reference

12 December 2020

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

12 December 2020

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

12 December 2020

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

12 December 2020

Vogt-Koyanagi-Harada disease

1 reference

12 December 2020

Interferon Alpha Treatment and Thyroid Dysfunction

1 reference

12 December 2020

Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

1 reference

12 December 2020

Ocular involvement in Adamantiades-Behçet's disease in Berlin, Germany

1 reference

12 December 2020

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease

1 reference

12 December 2020

Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed

1 reference

12 December 2020

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

1 reference

12 December 2020

Behcet's disease in Iran: analysis of 6500 cases.

1 reference

12 December 2020

Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis

1 reference

12 December 2020

Cytokines and Behcet's disease

1 reference

12 December 2020

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

1 reference

12 December 2020

Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.

1 reference

12 December 2020

Behçet's syndrome pathophysiology and potential therapeutic targets

1 reference

12 December 2020

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

1 reference

12 December 2020

Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

1 reference

12 December 2020

Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a

1 reference

12 December 2020

In vivo and in vitro IL-18 production during uveitis associated with Behçet disease: effect of glucocorticoid therapy

1 reference

12 December 2020

Pathogenesis of Behçet's disease: autoinflammatory features and beyond

1 reference

12 December 2020

Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis

1 reference

12 December 2020

Long-term Efficacy of Interferon in Severe Uveitis Associated with Behçet Disease.

1 reference

12 December 2020

Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.

1 reference

12 December 2020

Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study

1 reference

12 December 2020

Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy.

1 reference

12 December 2020

Identifiers

DOI

10.1177/2040622319847881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105923%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference